---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Generate Biomedicines

🌎 generatebiomedicines.com

Generate Biomedicines is a pioneering therapeutics company that operates at the intersection of biology, machine learning, and biological engineering. Founded in 2018, the company focuses on generative biology to create breakthrough therapeutics, utilizing a data-driven approach to develop novel proteins for therapeutic purposes.

---

Generate Biomedicines - Latest News and Updates

• Ariana Igneri has joined Generate Biomedicines as Director Global Regulatory Affairs in the United States, previously holding a position at another company.
• On April 29, Tom Doughty, Chief Information Security Officer at Generate Biomedicines, will join a panel with industry leaders from Blackstone and Wells Fargo.
• Generate Biomedicines is currently hiring for the position of Director, Technical Program Management in the United States.
• Generate Biomedicines published research on two pan-sarbecovirus antibodies identified using their generative optimization approach.
• Generate Biomedicines is hiring a remote Vice President of Clinical Operations to lead and expand their global clinical development programs.

• Generate Biomedicines' CEO Mike Nally and CTO Gevorg Grigoryan discussed their scientific collaboration with Amgen's EVP and CTO David Reese in a new video from TD Cowen.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.